Nanoantagonists with nanophase-segregated surfaces for improved cancer immunotherapy | |
Ma, Yang1,2; Qiao, Sheng-Lin1,2; Wang, Yi1,2; Lin, Yao-Xin1; An, Hong-Wei1; Wu, Xiao-Chun3; Wang, Lei1; Wang, Hao1,2 | |
刊名 | Biomaterials |
2018-02-01 | |
卷号 | 156页码:248-257 |
关键词 | Thermosensitive polymer Nanophase segregation Immune checkpoint Cancer Immunotherapy |
ISSN号 | 0142-9612 |
DOI | 10.1016/j.biomaterials.2017.11.048 |
通讯作者 | Wang, hao(wanghao@nanoctr.cn) |
英文摘要 | The blockade of pd-1/pd-l1 interaction by peptide antagonists can unleash and enhance pre-existing anti-cancer immune responses of t cells to eradicate cancer cells. however, low proteolytic stability is the "achilles' heel" of peptides. here, we first report a nanoantagonist with a physiological temperature sensitive nanophase-segregated surface that exhibits significantly enhanced blood circulation, peptide stability and pd-l1 immune checkpoint blockade efficacy. thermosensitive polymers with different phase transition temperatures (tt) are used to form the nanophase-segregated surface on an au nanorod core. importantly, the nanophase-segregated surface aids the nanoantagonist to resist protein adsorption and enhance the systemic stability of the linked peptides. finally, the as-designed nanoantagonist effectively blocks pd-1/pd-l1 interaction in vitro and in vivo, enhances the pre-existing cd8(+) t cell tumor destruction capability and inhibits tumor growth. this study offers a new strategy for designing nano formulations for cancer immunotherapy. (c) 2017 elsevier ltd. all rights reserved. |
WOS关键词 | CHECKPOINT BLOCKADE ; GOLD NANOPARTICLES ; IN-VIVO ; RADICAL POLYMERIZATION ; MONOCLONAL-ANTIBODIES ; THERAPEUTIC PEPTIDES ; IMMUNITY ; MICELLES ; B7-H1 ; SHELL |
WOS研究方向 | Engineering ; Materials Science |
WOS类目 | Engineering, Biomedical ; Materials Science, Biomaterials |
语种 | 英语 |
出版者 | ELSEVIER SCI LTD |
WOS记录号 | WOS:000419539100019 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2177868 |
专题 | 高能物理研究所 |
通讯作者 | Wang, Hao |
作者单位 | 1.Natl Ctr Nanosci & Technol NCNST, CAS Key Lab Biomed Effects Nanomat & Nanosafety, CAS Ctr Excellence Nanosci, Beijing 100190, Peoples R China 2.UCAS, Beijing 100049, Peoples R China 3.Natl Ctr Nanosci & Technol NCNST, CAS Key Lab Standardizat & Measurement Nanotechno, Beijing 100190, Peoples R China |
推荐引用方式 GB/T 7714 | Ma, Yang,Qiao, Sheng-Lin,Wang, Yi,et al. Nanoantagonists with nanophase-segregated surfaces for improved cancer immunotherapy[J]. Biomaterials,2018,156:248-257. |
APA | Ma, Yang.,Qiao, Sheng-Lin.,Wang, Yi.,Lin, Yao-Xin.,An, Hong-Wei.,...&Wang, Hao.(2018).Nanoantagonists with nanophase-segregated surfaces for improved cancer immunotherapy.Biomaterials,156,248-257. |
MLA | Ma, Yang,et al."Nanoantagonists with nanophase-segregated surfaces for improved cancer immunotherapy".Biomaterials 156(2018):248-257. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论